Microbot Medical is a pre-clinical medical device company engaged in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Co.'s technological platforms include LIBERTY®, NovaCross, One & Done, ViRob and TipCAT. Utilizing the LIBERTY and One & Done platforms, Co. is developing disposable robot for various endovascular interventional procedures. In addition, Co. is focused on the development of a Multi Generation Pipeline Portfolio utilizing all of its proprietary technologies. Co. is exploring the use of the TipCAT for minimally invasive neurosurgical and endovascular applications to complement its other technologies. The MBOT YTD return is shown above.
The YTD Return on the MBOT YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether MBOT YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the MBOT YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|